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Abstract
With newer information indicating more favorable outcomes of intensive care therapy for lung cancer patients,
intensivists increasingly are willing to initiate an aggressive trial of this therapy. Concerns remain, however, that the
experience of the intensive care unit for patients with lung cancer and their families often may be distressing.
Regardless of prognosis, all patients with critical illness should receive high-quality palliative care, including
symptom control, communication about appropriate care goals, and support for both patient and family
throughout the illness trajectory. In this article, we suggest strategies for integrating palliative care with intensive
care for critically ill lung cancer patients. We address assessment and management of symptoms, knowledge and
skill needed for effective communication, and interdisciplinary collaboration for patient and family support. We
review the role of expert consultants in providing palliative care in the intensive care unit, while highlighting the
responsibility of all critical care clinicians to address basic palliative care needs of patients and their families.
Introduction
Appropriate use of intensive care therapies for patients
with lung cancer is a topic of continuing research and
clinical interest. There has been a focus on issues related
to intensive care unit (ICU) triage decision-making, such
as whether expectations for clinically meaningful out-
comes justify the burdens and costs of critical care treat-
ment for lung cancer patients, and whether predictors at
the time of ICU admission or during a trial of intensive
care can help to refine our evaluation of potential risks
and benefits [1-6]. As new data emerge from studies of
lung cancer screening, staging, drug development, and
molecular diagnostics, prospects for reducing mortality
from this disease appear to be growing [7], whereas
advances in critical care are concomitantly improving
outcomes for ICU patients. These data, including speci-
fic information about outcomes of intensive care therapy
for patients with lung cancer, have driven an increasing
receptivity on the part of intensivists to initiate this
therapy and to pursue it aggressively, at least for a time-
limited trial [1,3,4,6,8]. Concerns remain, however, that
the experience of the ICU for lung cancer patients and
families, and their longer-term outcomes, often may be
unfavorable [9].
In this article, we start from the assumption that lung
cancer patients will continue to be cared for in ICUs,
likely with increasing frequency, in the foreseeable future
[10]. We also accept the premise that all patients with
critical illness, regardless of prognosis, should receive
high-quality palliative care comprising the following core
elements: alleviation of symptom distress; communica-
tion about care goals; alignment of treatment with
patients’ values and preferences; transitional planning;
and support for both patient and family throughout the
illness trajectory [11-14]. For our framework, we favor a
concurrent model in which palliative care and intensive
care are provided together as synergistic approaches,
rather than a sequential model that defers palliative care
until intensive care fails [15]. Accumulating data suggest
that early and ongoing integration of palliative care can
enhance the effectiveness of disease-directed treatment
for patients with serious illness, including lung cancer
[16]. Based on existing evidence, we suggest strategies for
integrating palliative care with intensive care for critically
ill lung cancer patients and their families.
Symptom distress: assessment and management
Many clinicians still understand “comfort care” as a
euphemistic code for limitation of intensive care and
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disease-directed therapies. Seen as an end-of-life
approach exclusively, “comfort care only” begins when
such therapies are withheld or withdrawn from patients
who are expected to die imminently. Yet, this narrow
view of the role of symptom control for critically ill
patients lacks empirical support and ignores evidence
that alleviation of physical and psychological distress
can mitigate maladaptive physiologic responses to such
distress while facilitating stability and recovery [16-20].
Systematic assessment and effective management of
symptoms are key components of comprehensive care
for lung cancer and other patients with critical illness,
including those receiving aggressive treatments to
extend life.
Symptom burden is significant across the trajectory of
lung cancer, from the time of diagnosis through
advanced stages of illness and even after survival of
treatment with curative intent. Patients with lung cancer
experience a broad range of symptoms [21-27] that are
associated not only with patient distress and impair-
ments of function and quality of life [24,25,27] but with
poorer survival [18,19,28,29]. A recent study of 276
patients with lung cancer who were interviewed within
the first months after diagnosis, among whom a majority
had stage I or II disease, found that more than 1 in 5
patients rated pain within the prior week at the highest
levels on the scale ("quite a bit” and “very much”) [30].
Patients with cancer often have multiple different types
of pain: including somatic pain from involvement by the
primary tumor or metastases of pleura, ribs, chest wall,
spine, or other bones; neuropathic pain from chest or
brachial plexus nerve involvement; visceral pain from
tumor invasion of various organs; and pain associated
with anticancer therapy, including surgery [31]. Among
a large cohort of hospitalized patients with advanced
lung cancer, more than 25% reported severe pain and/or
dyspnea; of those dying within 2 months, 35% had
severe pain and 46% had severe dyspnea at least half the
time in the hospital [32]. Psychological distress is more
prevalent in lung cancer patients than those with other
solid tumors [33], affecting even those receiving success-
ful disease-directed treatment as well as others [34-37]
and interacting with and exacerbating other symptoms,
such as pain [38].
Limited evidence describes the symptom experience of
critically ill patients with malignancy. In a prospective
study of 100 medical ICU patients with a present or
past diagnosis of cancer and a hospital mortality rate of
56%, 50 were able to provide self-reports of symptoms
assessed by the Edmonton Symptom Assessment Scale
[39]. Between 55% and 75% of responders rated pain,
discomfort, anxiety, sleep disturbance, or unsatisfied
hunger or thirst as moderate or severe. Dyspnea and
depression at these levels were reported by
approximately 33% and 40% of responders. A retrospec-
tive study reviewing the experience of 88 cancer patients
seen in consultation in the ICU by the hospital’s pallia-
tive care team found that eight of ten symptoms in the
Edmonton Symptom Assessment Scale were reported by
60% or more of the patients; pain and dyspnea were
reported by more than three-quarters of patients [40].
Another study evaluated presence, intensity, and distress
of multiple symptoms through more than 400 interviews
with 171 critically ill patients deemed to be at high risk
of dying (one-third died), of whom 22% had cancer [41].
Pain and shortness of breath were reported in 40% and
44% of these assessments, respectively; between 50% and
75% of assessments revealed anxiety, thirst, and fatigue,
and many patients also reported other physical and psy-
chological symptoms. In a prospective, observational
study conducted in 44 ICUs in France, assessing almost
1,400 patients, including 16% with active cancer and 6%
receiving recent chemotherapy for cancer, more than
half of patients providing ratings on a visual analog or
verbal descriptive scale reported pain at substantial
levels [42]. As intensivists reduce the use of sedating
medications to promote shorter duration of mechanical
ventilation and earlier patient mobilization, an even
higher prevalence and intensity of physical and emo-
tional symptoms during acute critical illness may be
unmasked.
Systematic symptom assessment, as recommended by
major societies representing critical care professionals
[43] and included within standards of The Joint Com-
mission [44], is the cornerstone of effective symptom
control. A before-after study in a medical-surgical ICU
in France found that an intervention consisting of regu-
lar, frequent, and standardized assessments by nurses
with required reporting of pain or agitation above speci-
fied threshold levels was associated with significant
decreases in the incidence of pain and agitation, closer
titration of analgesic and psychoactive drugs, shorter
duration of mechanical ventilation, and fewer nosoco-
mial infections [45]. That is, pain control and other out-
comes improved with assessment, in the absence of a
protocol mandating treatment. For self-reports of symp-
toms, which remain the “gold standard” of assessment,
palliative care researchers have developed simple, practi-
cal symptom measurement tools that avoid undue bur-
den and provide sufficient information for clinical
management. Examples that measure a diverse group of
symptoms included the Condensed Form of the Memor-
ial Symptom Assessment Scale [46], which can be modi-
fied for use with critically ill patients [47], and the
Edmonton Symptom Assessment Scale [48]. Abbreviated
instruments also are available to evaluate specific symp-
toms, such as pain [49], dyspnea [50], and depression
[51]. Several tools are available to assess symptoms,
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such as pain and dyspnea, with patients who cannot
self-report because of impaired cognition and/or inabil-
ity to communicate, which often occurs in the ICU:
these include the Behavioral Pain Scale [52], Critical
Care Pain Observation Tool [53], Assume Pain Present
approach [54], and Respiratory Distress Observation
Scale [55]. Lung cancer-specific assessment tools include
a composite of the 3-symptom subscales (physical well-
being, emotional well-being, and lung cancer-specific
concerns-totaling 20 items) of the Functional Assess-
ment of Cancer Therapy-Lung (FACT-L) [56], and the
13-item lung-cancer-specific module supplementing the
European Organization for Research and Treatment of
Cancer-Quality of Life Questionnaire (EORTC-QLQ-
LC13) [57]. These tools were designed and validated as
research instruments, however, and would be difficult to
use in clinical care of critically ill patients.
The National Comprehensive Cancer Network pub-
lishes and annually updates robust clinical practice
guidelines for treatment of cancer pain [58]. Although
other expert recommendations specifically address man-
agement of pain and other symptoms in patients with
lung cancer [38,59], these are not readily applied in the
context of critical illness. On the other hand, general
recommendations for analgesic management of critically
ill patients [43] need further support from rigorous,
large-scale trials and may not account for specific needs
of patients with lung cancer and other malignancies,
whose acute distress often is superimposed on chronic
pain and other symptoms and attributable both to the
underlying disease and to anticancer therapies. Of parti-
cular concern in ICUs is the practice of undertreating
pain and other symptoms in the face of instability
resulting from the critical illness, sometimes accepting a
patient’s distress rather than increasing vasopressor or
ventilator support to address underlying issues, such as
sepsis-induced hypotension or encephalopathy.
Given the range of barriers to effective management of
pain in the ICU setting, structured approaches may
improve ICU pain treatment [60]. Suggestions include
involvement of an interdisciplinary team to develop an
improvement process, implementation of tools, such as
clinical paths and checklists, incorporation of analgesic
management approaches within electronic health
records and computerized provider order entry systems,
and referrals for specialist input on particularly challen-
ging cases [60], Clinicians on the ICU team should have
basic knowledge of equianalgesic opioid dosing; this
information is easily incorporated in computer-based
ordering systems and/or on pocket cards for clinicians
[61]. In addition, recognition and proactive management
of common side effects of opioid treatment are impor-
tant competencies for critical care practice. Therapeutic
strategies can refer to evidence-based guidelines for
palliative care of cancer patients [58], although these do
not speak directly to care in ICU settings. For specific
issues that arise frequently in the ICU, such as the
increased risk in renal failure of neurotoxicity from
accumulation of active metabolites of morphine [62,63],
targeted education and system supports (e.g., automatic
pharmacy warnings) are appropriate.
For dyspnea, which is reported by patients receiving
mechanical ventilation [64] as well as others with critical
illness, opioids remain the most effective pharmacologic
treatment and usually are therapeutic at much lower
doses than are needed for pain [65,66]. Other interven-
tions for dyspnea in lung cancer patients are reviewed
elsewhere [38,67,68]. However, empirical data on man-
agement of dyspnea in the ICU are scant. The role of
palliative noninvasive ventilation for life support and for
relief of dyspnea in patients who are not receiving endo-
tracheal mechanical ventilation is still being defined
[69,70]. As discussed more fully below, specialists in pal-
liative care, where available, can help the ICU team with
the complex challenges that may arise when providing
life-prolonging measures along with symptom control.
Communication with lung cancer patients and their
families during critical illness
Recent data document that across all stages of the dis-
ease, many lung cancer patients have not communicated
with clinicians primarily responsible for their oncologic
care about key issues related to treatment decision-mak-
ing, including preferences for use of intensive care
therapies [30,71]. For example, a recent, prospective
study used a standardized questionnaire to obtain
patient ratings of the extent of communication with
lung cancer physicians about 11 important topics,
including prognosis, potential complications of therapy,
care goals, life support preferences, proxy appointment,
living will preparation, symptoms, and other concerns
[30]. Among 276 patients at 4 major medical centers in
New York City, 1 in 5 reported that their physicians
communicated “not at all” or “a little bit” on all topics
in the questionnaire; 40% gave these low ratings to com-
munication about the chances of curing the lung cancer;
and more than 80% reported low levels of communica-
tion regarding resuscitation/life-sustaining treatment
and preparation of an advance directive. However, 40%
of the study patients who had a preference with respect
to resuscitation stated that they would not want resusci-
tation to be attempted in the event of an arrest, and
60% would not want mechanical ventilation for respira-
tory failure. Overall, 52% of patients reported that com-
munication with physicians was inadequate, a
proportion that was similar across patients of all patho-
logic stages. In the U.S. Cancer Care Outcomes
Research and Surveillance (CanCORS) study, barely 50%
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of more than 1,500 patients with stage IV lung cancer
reported discussing hospice with a care provider, yet
more than 70% of those patients died within 6 months
(the time period for hospice eligibility) of the study
interview [72]. The majority of more than 4,000 physi-
cians caring for CanCORS patients indicated that,
despite national guidelines recommending discussion of
prognosis, resuscitation status, hospice, and preferred
site of death with patients expected to die within a year,
they would not initiate such a discussion even if death
were expected within 6 months. Rather, they would
postpone discussions until the patient became sympto-
matic or failed disease-directed treatment and might
never conduct these discussions unless initiated by the
patient or family [71].
Physicians’ reluctance to discuss prognosis, prefer-
ences for intensive care therapies, and issues related to
end-of-life care reflects in part concerns that such com-
munication would extinguish hope or worsen emotional
distress [73]. Research shows, however, that cancer
patients and their families generally prefer to be
informed even if the disease is incurable and most
patients favor early disclosure of poor prospects [74,75].
Similarly, most surrogates of patients with critical illness
understand and accept that physicians cannot prognosti-
cate with certainty but still prefer to discuss expecta-
tions for outcomes even if they are uncertain or
unfavorable [76]. Most of these surrogates believe that
physicians should not withhold information about prog-
nosis as a way to preserve hope and consider prognostic
information to be essential for emotional and practical
preparation [76]. In a U.S. multisite study of patients
with advanced cancer and their informal caregivers,
rates of major depressive disorder were not higher
among patients who had discussed preferences for care
at the end of life with their physicians, but were higher
among bereaved caregivers of patients who had not had
such discussions [77]. In fact, compared with those
receiving standard oncologic care alone, ambulatory out-
patients with advanced lung cancer who also received
consultation from palliative care specialists addressing
understanding of the illness, treatment decision-making,
and development of care plans had better mood and
quality of life along with improved understanding of
their prognosis [16]. On the other hand, cancer patients
who overestimate their chances of survival are more
inclined to choose treatments for which burdens out-
weigh potential benefits [78], less likely to discuss care
preferences with their surrogate decision-makers [79],
and less likely to obtain information that might improve
the quality of their experience at the end of life [72].
Successful communication about care goals requires
both knowledge and skill on the part of clinicians, who
should review recent data on outcomes of ICU
treatment for critically ill patients with lung cancer and
master evidence-based approaches for communicating
with such patients and their families. Whereas older stu-
dies suggested that potential benefits of intensive care
for patients with lung cancer rarely justified burdens
and costs, short-term survival after treatment for critical
illness seems to be improving for patients with lung
cancer as for those with other malignancies. ICU and
hospital survival rates of 78% and 60%, respectively,
were documented in a retrospective study of 139 lung
cancer patients admitted between 1998 and 2005 to the
medical ICU of a university-affiliated medical center in
the United States [1]. For patients who required
mechanical ventilation, who comprised half of the
cohort, ICU survival was 62% and 47% were alive at
hospital discharge [1]. In hospitals in France and Brazil
that specialize in cancer care, hospital survival among
143 patients with lung cancer in two medical ICUs was
approximately 40% overall and 30% for 100 patients in
the study group who were mechanically ventilated [4]. A
separate, retrospective study conducted in a lung cancer
referral center in France evaluated 6-month survival for
105 consecutive lung cancer patients, including more
than 80% with advanced non-small cell or disseminated
small cell cancer but excluding those who had under-
gone surgical resection of lung cancer during the same
hospital stay [5]. Although 6-month survival was less
than 30%, two-thirds of the ICU survivors were able to
receive anticancer treatments after discharge. A retro-
spective study of 103 patients with unresectable lung
cancer in three French ICUs found a 3-month survival
rate of 37%, and 12% of patients were alive at 1 year [3].
In studies of heterogeneous cohorts of cancer patients
and of lung cancer patients specifically, factors asso-
ciated with poorer outcome have included poor perfor-
mance status before ICU admission [2,3,5], need for
vasopressor support [6,80,81], cancer disease progression
[2,5], use of invasive mechanical ventilation [3,5,6], and
persistent or worsening organ dysfunction after several
days of ICU treatment [3]. Such data can be helpful to
clinicians to prepare for discussions with lung cancer
patients and families about achievable goals of intensive
care.
Other data are relevant for informing discussions of
resuscitation status, because risks and benefits of cardio-
pulmonary resuscitation (CPR) in case of an arrest are
distinct from those of a trial of intensive care. A
national study of CPR outcomes in critically ill patients
in the United States included patients with hematologic
or metastatic cancer, who comprised 11% of the cohort
of almost 50,000 patients [82]. For the entire cohort,
survival to hospital discharge was less than 16% and the
proportion discharged to home was 8.5%. Among those
who required vasopressors or mechanical ventilation,
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outcomes were worse [82]. Fewer than 4% of patients
who received vasopressors and CPR were discharged to
home, and still fewer went home with a favorable neu-
rological outcome [82]. Mechanical ventilation was asso-
ciated with 40% lower odds of hospital survival after
CPR [82]. Although the presence of malignancy, by
itself, has not been identified as an independent predic-
tor of hospital survival or functional outcome after CPR,
the prognosis of the underlying cancer along with the
nature and evolution of the critical illness provide a
context for discussing resuscitation status. Data suggest
that in practice, resuscitation status has not been clari-
fied before ICU admission for most lung cancer patients
[30,40,83] (who then are “full code” by default) but that
a “Do Not Resuscitate” directive is entered before death
for approximately half of these patients [83].
Qualitative investigations of clinician communication
in the ICU and in outpatient cancer care settings sug-
gest specific skills and approaches to improve the effec-
tiveness of this communication. Listening is a key skill
in which few physicians have received training or
achieved mastery. Audio recordings of ICU family con-
ferences reveal that physicians generally dominate these
discussions, leaving little opportunity for active partici-
pation by the family, investigation of the patient’s values
and preferences, or attention to family concerns [84].
Yet, family satisfaction with these conferences is asso-
ciated with the proportion of time in which the family is
speaking relative to the time in which clinicians are
speaking to them [85]. To encourage comments and
questions from family members, the “Ask-Tell-Ask”
approach has been described [86]. The clinician begins
the discussion by asking family members to report their
understanding of a situation (e.g., the patient’s condition
and prognosis), including what they have been told by
other clinicians, and by asking permission to continue
with the discussion. The clinician then provides a suc-
cinct update of the situation in layperson’s terms, show-
ing sensitivity to differences in health literacy and
cultural background. The family is then asked again to
summarize the discussion, comment, ask questions, and
share concerns. A rigorous process, including literature
review, surveys of critical care clinicians, and structured
interviews of clinicians and families, identified questions
of importance to family members in the ICU [87], and
these questions could be specifically explored by clini-
cians if not brought forward by families themselves.
Evidence also indicates the importance of acknowled-
ging and addressing emotions during clinician commu-
nication with seriously ill patients and their families,
while documenting that physicians often fail to demon-
strate this skill [84,88,89]. Strong emotions can over-
whelm the ability to absorb and integrate information
needed by the patient and family to make rational
decisions about treatment or establish appropriate care
goals. Thus, clinicians should incorporate explicit
expressions of empathy, which help to control emotional
fluctuations and distractions, and thereby enhance cog-
nitive processing of important clinical information. The
acronym “N.U.R.S.E.” abbreviates statements that com-
municate empathy explicitly: Name the emotion to
make clear that it is recognized; express Understanding
in an open and compassionate way; show Respect for
the person experiencing the emotion; communicate
Support; and Explore the emotional experience of the
other person in greater depth [89]. Examples of
empathic statements in these domains are available as
guides for clinicians [89,90].
For communication addressing limitation of ICU
therapies, data show that families are more satisfied
when clinicians provide assurance that the patient will
not be abandoned before death and will not suffer, and
support the family’s decision whether it is to forgo or to
continue therapy [91]. Expert recommendations have
been provided for communicating with patients and
family members who choose to continue life-supporting
treatments in the hope that a miracle will occur [92],
and those who demand “everything,” including treat-
ments deemed nonbeneficial by clinicians.
Support of the ICU family
Evidence of the emotional, physical, and practical bur-
dens for families of seriously ill patients, including those
who receive intensive care treatment, continues to accu-
mulate. Depression and anxiety are prevalent among
ICU families, as are acute and posttraumatic stress
symptoms that can persist and even increase over time
[93,94]. Responsibility for making life-death decisions as
surrogates weighs heavily [76,95]. For families whose
loved ones die in the ICU or soon after, which is still
common for critically ill patients with lung cancer, grief
often is complicated [93,96]. In follow-up interviews
with bereaved family members of patients who died in
the ICU, one-third met DSM-IV criteria for at least one
psychiatric disorder (major depression, generalized anxi-
ety, panic, or complicated grief) [96]. Many families of
ICU survivors, especially those facing an ongoing serious
illness, such as lung cancer, remain burdened in multi-
ple ways and over long periods. Qualitative research
captures themes of regret, exhaustion, isolation, and
hopelessness as expressed in caregivers’ own words [97].
Personal and professional lives may be disrupted [98].
Among families of patients who received mechanical
ventilation for as little as 3 days, post-ICU decrements
in physical health and health-related quality of life are
common, and the experience of role overload intensifies
over time [98,99]. Informal caregivers who feel strained
by this role are known to be at higher risk of mortality
Gay et al. Annals of Intensive Care 2012, 2:3
http://www.annalsofintensivecare.com/content/2/1/3
Page 5 of 10
[100]. Thus, the term “post-intensive care syndrome,”
which was recently recommended by a consensus of
experts to describe “new or worsening impairments in
physical, cognitive, or mental health status arising after
critical illness and persisting beyond acute care hospita-
lization,” is applicable to family members as well as to
surviving ICU patients [101]. Support for family mem-
bers enables them to function more effectively as care-
givers and surrogate decision-makers, thereby also
benefiting patients and clinicians. Both patients and
family members identify family care as a core domain of
high-quality palliative care in the ICU [14].
Randomized, controlled research shows that proactive,
sensitive, and structured communication by clinicians
improves psychological well-being of ICU families as
well as their satisfaction. For families facing the immi-
nent death of a loved one in the ICU, an intervention,
including a protocol-driven discussion with clinicians
and a brochure addressing bereavement, was associated
with a lower prevalence and severity of posttraumatic
stress disorder, anxiety, and depression at 3-month fol-
low-up [102]. A variety of other printed informational
aids have been developed to support and supplement
clinician counseling of ICU families [103,104], including
a Family Meeting Brochure intended to guide families in
preparing for a face-to-face discussion about the
patient’s condition, prognosis, and appropriate goals of
care [103,105]. A leaflet providing general information
about the ICU improved family understanding of acute
critical illness and treatment and increased family satis-
faction [106]. A brochure developed and validated to
provide information and prompt further discussion
about protracted critical illness includes the potential
long-term impact on the patient’s cognition and func-
tion and burdens faced by families [104]. As research
continues to clarify outcomes for patients with lung can-
cer and other malignancies, who undergo treatment for
critical illness, this knowledge might be incorporated in
printed aids and other educational resources to help
families anticipate and manage challenges they face.
Patients as well as families place high value on family
access and proximity to the patient [14]. Patients report
their awareness of family presence and the comfort and
strength it gives them. Families identify many important
functions they serve, including their role as advocates,
monitors, protectors, interpreters, caregivers, and deci-
sion-makers [14,107]. In addition, families perceive their
presence as essential for optimal communication with
the ICU team and for alleviation of their own distress
[14]. These data provide support for a liberal approach
to family visiting [108-110]. Although clinicians might
prefer that families leave the bedside during daily ICU
rounds, some have adapted their practice to allow
families not only to remain but to participate [109], an
approach recommended by a consensus of expert opi-
nion [109]. If skillfully led and coordinated, such rounds
can help to address family needs for information and
support without distracting from the care of critically ill
patients, education of intensive care trainees, or other
exchanges within the ICU team.
Contributions from multiple members of the inter-
disciplinary ICU team enhance support for families
[14]. The role of the nurse in optimally integrating pal-
liative care with intensive care has been emphasized
[111]. Among other essential functions, nurses can
help to report patient symptoms and family concerns
and to communicate about achievable goals of treat-
ment that are consistent with patient preferences
[111]. Other disciplines, such as pastoral care and
social work, also provide perspectives and services that
complement the work of the medical team. More
research needs to focus on models for coordinating
interdisciplinary input to strengthen family support
within a comprehensive framework of care for critically
ill patients with lung cancer or other conditions during
the ICU stay and beyond.
Role of expert consultants in providing palliative care in
the ICU
Following a decade of exponential growth, palliative care
specialists are now available at 85% of acute care hospi-
tals with 300 or more beds and half of hospitals with at
least 50 beds in the United States [112,113]. In 2006,
the subspecialty of palliative medicine achieved recogni-
tion by the American Board of Medical Specialties,
receiving broad cosponsorship from an unprecedented
number of specialty boards. The field of palliative care
also is growing in other countries. When available, spe-
cialists in palliative care can provide expert input on
management of symptoms, discussions of care goals,
and family support for critically ill patients with lung
cancer and others with serious and complex illness.
They can assist with transitional planning and provide
continuity across multiple venues of care. Some ICUs
have adopted a “consultative model,” giving palliative
care specialists a major role, particularly in the care of
patients at highest risk for poor outcomes [114]. Consul-
tations may be “triggered” by specified criteria, which
could include a diagnosis of advanced cancer [115], or a
palliative care clinician may join ICU rounds on a regu-
lar basis to help with timely identification of patients
and families who could benefit from expert input
[116,117]. In other ICUs, where an “integrative model”
is used, the critical care team incorporates palliative care
principles and interventions for all patients and families
in the ICU [114]. A third model blends features of the
other two, relying on the ICU team to meet basic pallia-
tive care needs of patients and families while engaging
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specialists for more complex or refractory problems
[114].
Benefits of consultation by palliative care specialists
include improved symptom control, clearer family
understanding of diagnosis and prognosis, more efficient
utilization of ICU resources, and enhanced patient and
family satisfaction [16,115,118-120]. In a recent, rando-
mized, controlled trial, early integration of palliative care
with standard oncologic care for ambulatory patients
with stage IV lung cancer was associated not only with
better mood and quality of life but also with longer sur-
vival compared with standard oncologic care alone [16].
The National Comprehensive Cancer Network and
American Society of Clinical Oncology support early
integration of palliative care for all cancer patients
[121,122]. The American College of Chest Physicians’
Evidence-Based Clinical Practice Guidelines for Diagno-
sis and Management of Lung Cancer support integration
of palliative care, including involvement of a palliative
care consultation team, specifically extending its recom-
mendations to include patients pursuing curative or life-
prolonging therapies [123]. Utilization of palliative care
consultative services in the care of ICU and other hospi-
talized patients with lung cancer has been described
[40,124].
Even where they are available to provide consultative
input, existing data indicate that palliative care specia-
lists are underutilized for lung cancer patients. A recent
survey of physicians caring for lung cancer patients at
five separate medical centers with established, interdisci-
plinary palliative care teams found that among 155
(78%) responders, half reported referring < 25% of these
patients for palliative care consultation [125]. In multi-
ple regression analysis, physicians’ belief that referral to
a palliative care specialist would alarm patients and
families was a significant predictor of low referral,
whereas the belief that palliative care specialists spend
more time discussing complex issues was a significant
predictor of more frequent referral. In a study of pallia-
tive care consultations for lung cancer patients who
received treatment in the ICU of a large comprehensive
care center, among whom three-quarters had multiple
comorbid conditions, the mean duration between ICU
admission and referral to the palliative care service was
10 days [40]. More than 90% of these referrals were
made by the primary oncology team, whereas less than
10% were from the ICU team. The vast majority of
these patients were experiencing severe symptom dis-
tress and delirium, which improved after interventions
by the palliative care team. In addition, although few
(12%) patients had an advance directive before the con-
sultation, and most (81%) had “full code” status at that
time, decisions were made not to attempt resuscitation
in the event of arrest for 70% of patients after
discussions with the interdisciplinary palliative care
team, which included a social worker, psychiatric nurse
counselor, and pastoral care provider. More than 40% of
the lung cancer patients seen in palliative care consulta-
tion were alive at hospital discharge. Such data support
assiduous efforts to ensure timely access to specialist
palliative care for a broader group of patients.
Conclusions
The future is likely to bring an increasing number of
critically ill patients with lung cancer to the ICU.
Although specialists in palliative care will be increasingly
available, attention to basic palliative care needs of
patients and families remains an ongoing responsibility
for intensive care clinicians. Critical care and palliative
care are not mutually exclusive but, rather, mutually
enhancing approaches to the care of ICU patients,
including those with lung cancer. Through early and
continuing integration of these approaches, intensivists
can improve patient and family well-being while opti-
mizing disease-directed and restorative treatments.
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